Hyperaldosteronism: Difference between revisions

Jump to navigation Jump to search
Line 11: Line 11:
== Classification ==
== Classification ==
Aldosteronism and mineralocorticoid excess may be classified into two types, primary hyperaldosteronism (conn's syndrome) and secondary hyperaldosteronism. The different types of aldosteronism described in the below table:
Aldosteronism and mineralocorticoid excess may be classified into two types, primary hyperaldosteronism (conn's syndrome) and secondary hyperaldosteronism. The different types of aldosteronism described in the below table:


{| class="wikitable"
{| class="wikitable"
! rowspan="2" |
!High renin causes
! rowspan="2" |
!Disease
! rowspan="2" |Cause
!
! colspan="4" |Laboratory
!
|-
!Renin activity
!Aldosterone levels
!urinary free cortisone
!
!
|-
|-
|Primary hyperaldosteronism
| rowspan="2" |Genetic mutation
|[[Renin-producing tumors]]
|Bartter and Gitelman syndromes
|Hyperplasia of the juxtaglomerular apparatus (the source of renin in the kidney),
|
|
|↑
|↑
|↓
|
|
|-
|-
|Secondary hyperaldosteronism
|Liddle syndrome or pseudohypoaldosteronism type 1
|[[Apparent mineralocorticoid excess]]
|due to resistance to the actions of aldosterone
|
|
|↓
|↓
|↓↓
|
|
|-
|-
| rowspan="4" |Renovascular
|Kidney transplant
|
|
|[[Licorice]] ingestion
|
|
|↓
|↓
|Moderate ↑
|
|
|-
|-
|Renin-secreting juxtaglomerular cell tumors
|
|
|Ectopic ACTH production
|
|
|↓
|↑
|Markedly ↑↑
|
|
|-
|-
|Scleroderma renal crisis
|
|
|Primary hyperaldosteronism
|
|
|↓
|↑
|↓
|
|
|-
|-
|Malignant hypertension
|
|
|Familial hyperaldosteronism
|
|
|↓
|↑
|↓
|
|
|-
|-
|Tumors
|Reninoma
|
|
|Cushing syndrome
|
|
|↓
|↑
|Markedly ↑↑
|
|
|-
|-
|Intravascular hypovolemia
|heart failure, hepatic cirrhosis, and nephrotic syndrome
|
|
|
|
|Renal artery stenosis
|}
 
{| class="wikitable"
! rowspan="2" |Classification
! rowspan="2" |Disease
! rowspan="2" |Cause
! colspan="4" |Laboratory
|-
!Renin activity
!Aldosterone levels
!urinary free cortisone
!
|-
| rowspan="4" |Secondary hyperaldosteronism
|[[Renin-producing tumors]]
|
|
|↑
|↑
Line 87: Line 85:
|
|
|-
|-
|Renal artery stenosis
|
|
|
|
|[[Liddle's syndrome]]
|
|
|↓
|↓
|↓
|
|
|-
|-
|Cushing syndrome
|
|
|
|[[Diuretic]] use
|
|
|Nl
|
|
|↓
|
|
|-
|-
|
|Ectopic ACTH production
|[[17 alpha-hydroxylase deficiency|17 alpha hydroxylase deficiency]]
|
|
|↓
|↓
|
|
|
|Markedly ↑↑
|
|
|-
|-
|
| rowspan="2" |Primary hyperaldosteronism
|[[11β-hydroxylase deficiency|11 beta hydroxylase deficiency]]
|Primary hyperaldosteronism
|
|
|↓
|↓
|
|
|↓
|↓
|
|
|-
|-
|Familial hyperaldosteronism
|
|
|Coarctation of aorta
|
|
|
|
|
|↓
|↓
|
|
Line 135: Line 129:
! rowspan="2" |Cause
! rowspan="2" |Cause
!
!
! colspan="3" |Labratory
! colspan="4" |Labratory
!
!
|-
|-
Line 142: Line 136:
!Renin
!Renin
!Aldosterone
!Aldosterone
!Other
!Treatment
!Treatment
|-
|-
Line 151: Line 146:
| rowspan="2" |↓
| rowspan="2" |↓
| rowspan="2" |↓
| rowspan="2" |↓
|
| rowspan="2" |
| rowspan="2" |
|-
|-
|11b-hydroxylase
|11b-hydroxylase
|
|
|
|
|
Line 163: Line 160:
|↓
|↓
|↓
|↓
|Urinary free cortisone ↓↓
|dexamethasone and/or MR-blockers
|dexamethasone and/or MR-blockers
|-
|-
Line 171: Line 169:
|↓
|↓
|↓
|↓
|
|amiloride or triamterene can reverse the clinical picture reactivating the renin aldosterone
|amiloride or triamterene can reverse the clinical picture reactivating the renin aldosterone
|-
|-
Line 178: Line 177:
|
|
|
|
|↓
|
|
|
* ↓ if excess cortisol saturates 11-HSD2 enzyme activity
 
* ↑ in direct activation of renin angiotensin system activation by glucocorticoids
|Urinary free cortisol markedly ↑↑
|
|
|-
|-
Line 188: Line 191:
|↓
|↓
|↓
|↓
|
|dexamethasone
|dexamethasone
|-
|-
|Aldosterone-secreting adrenocortical carcinoma
|Aldosterone-secreting adrenocortical carcinoma
|
|
|
|
|
Line 204: Line 209:
|↓
|↓
|↓
|↓
|
|
|
|-
|-
Line 212: Line 218:
|↓
|↓
|↓
|↓
|
|thiazide diuretics and/or dietary sodium restriction
|thiazide diuretics and/or dietary sodium restriction
|-
|-
| rowspan="7" |Exogenous causes
| rowspan="7" |Exogenous causes
|Corticosteroids with mineralocorticoid activity
|Corticosteroids with mineralocorticoid activity
|
|
|
|
|
Line 224: Line 232:
|-
|-
|Hypersodic diets
|Hypersodic diets
|
|
|
|
|
Line 232: Line 241:
|-
|-
|Water intossications
|Water intossications
|
|
|
|
|
Line 239: Line 249:
|
|
|-
|-
|Licorice
|Licorice ingestion
|
|
|
|
|
|
|
|
|↓
|↓
|Urinary free cortisol Moderate ↑
|
|
|-
|-
|grapefruit
|grapefruit
|
|
|
|
|
Line 256: Line 268:
|-
|-
|Contraceptives
|Contraceptives
|
|
|
|
|
Line 264: Line 277:
|-
|-
|Some progestins
|Some progestins
|
|
|
|
|
Line 273: Line 287:
| rowspan="7" |Particular causes of hypertension
| rowspan="7" |Particular causes of hypertension
|Sclerosis of juxtaglomerular apparatus (diabetic microangiopathy and/or of the elderly)
|Sclerosis of juxtaglomerular apparatus (diabetic microangiopathy and/or of the elderly)
|
|
|
|
|
Line 281: Line 296:
|-
|-
|FANS
|FANS
|
|
|
|
|
Line 289: Line 305:
|-
|-
|B-Adrenergic agonists
|B-Adrenergic agonists
|
|
|
|
|
Line 297: Line 314:
|-
|-
|Aging
|Aging
|
|
|
|
|
Line 305: Line 323:
|-
|-
|Low-renin essential hypertension
|Low-renin essential hypertension
|
|
|
|
|
Line 313: Line 332:
|-
|-
|Autonomic dysfunction
|Autonomic dysfunction
|
|
|
|
|
Line 321: Line 341:
|-
|-
|Partial/total nephrectomy or removal of renal tissue
|Partial/total nephrectomy or removal of renal tissue
|
|
|
|
|

Revision as of 18:39, 15 September 2017

Hyperaldosteronism Main page

Patient Information

Overview

Classification

1- Primary hyperaldosteronism
2- Secondary hyperaldosteronism
3- Pseudohyperaldosteronism causes (low renin)

Differentiating diagonsis

History and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]

This page contains general information about Hyperaldosteronism. For more information on specific types, please visit the pages on Primary hyperaldosteronism, and Secondary hyperaldosteronism.

Synonyms and keywords: Aldosteronism

Overview

Classification

Aldosteronism and mineralocorticoid excess may be classified into two types, primary hyperaldosteronism (conn's syndrome) and secondary hyperaldosteronism. The different types of aldosteronism described in the below table:


High renin causes Disease
Genetic mutation Bartter and Gitelman syndromes Hyperplasia of the juxtaglomerular apparatus (the source of renin in the kidney),
Liddle syndrome or pseudohypoaldosteronism type 1 due to resistance to the actions of aldosterone
Renovascular Kidney transplant
Renin-secreting juxtaglomerular cell tumors
Scleroderma renal crisis
Malignant hypertension
Tumors Reninoma
Intravascular hypovolemia heart failure, hepatic cirrhosis, and nephrotic syndrome
Classification Disease Cause Laboratory
Renin activity Aldosterone levels urinary free cortisone
Secondary hyperaldosteronism Renin-producing tumors
Renal artery stenosis
Cushing syndrome
Ectopic ACTH production Markedly ↑↑
Primary hyperaldosteronism Primary hyperaldosteronism
Familial hyperaldosteronism

Pseudohyperaldosteronism causes:

Pseudohyperaldosteronism causes Disease Cause Labratory
Elevated mineralocorticoid Renin Aldosterone Other Treatment
Endogenous causes Deficiency of 17a-hydroxylase Deoxycorticosterone (DOC)
11b-hydroxylase
Apparent mineralocorticoid excess syndrome (AME) Genetic or acquired defect of 11-HSD Urinary free cortisone ↓↓ dexamethasone and/or MR-blockers
Liddle’s syndrome Mutation of the epithelial sodium channels (ENaC) gene in the distal renal tubules amiloride or triamterene can reverse the clinical picture reactivating the renin aldosterone
Cushing’s syndrome The main pathogenetic mechanism is linked to the excess

of cortisol which saturates 11-HSD2 activity, allowing cortisol to bind MR. A similar picture is also related to over secretion of cortisol by adrenocortical carcinomas. In some cases the disease is associated with secondary hyperaldosteronism due to a direct activation of the renin angiotensin system by glucocorticoids.

  • ↓ if excess cortisol saturates 11-HSD2 enzyme activity
  • ↑ in direct activation of renin angiotensin system activation by glucocorticoids
Urinary free cortisol markedly ↑↑
Insensitivity to glucocorticoids (Chrousos syndrome) mutations in glucocorticoid receptor (GR) gene Deoxycorticosterone (DOC) dexamethasone
Aldosterone-secreting adrenocortical carcinoma
Geller’s syndrome mutation of MR that alters its specificity and allows progesterone to bind MR severe hypertension particularly during pregnancy
Gordon’s syndrome or pseudohypoaldosteronism type 2 due to different mutations correlated to different phenotypes. Mutations of at least four genes have been identified, including WNK1 and WNK4 hypertension, characterized by hyperkalemia, normal renal function thiazide diuretics and/or dietary sodium restriction
Exogenous causes Corticosteroids with mineralocorticoid activity
Hypersodic diets
Water intossications
Licorice ingestion Urinary free cortisol Moderate ↑
grapefruit
Contraceptives
Some progestins
Particular causes of hypertension Sclerosis of juxtaglomerular apparatus (diabetic microangiopathy and/or of the elderly)
FANS
B-Adrenergic agonists
Aging
Low-renin essential hypertension
Autonomic dysfunction
Partial/total nephrectomy or removal of renal tissue

Differentiating Diagnosis

Hyperaldosteronism should be differentiated from other diseases causing hypertension and hypokalemia for example:

 
 
 
 
 
 
 
 
Hypertension and Hypokalemia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plasma renin activity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal or High (Plasma Renin/Aldosterone ratio <10
 
 
 
 
 
 
 
 
 
 
 
Suppressed (Plasma Renin/Aldosterone ratio >20
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Renin-secreting tumors
*Diuretic use
*Renovascular hypertension
*Coarctation of aorta
*Malignant phase hypertension
 
 
 
 
 
 
 
 
 
 
 
Urinary aldosterone
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Elevated
 
Normal
 
 
Low
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conn's syndrome (Primary aldosteronism)
 
Profound K+ depletion
 
 
• 17 alpha hydroxylase deficiency
• 11 beta hydroxylase deficiency
• Liddle's syndrome
• Licorice ingestion
• Deoxycortisone producing tumor
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Add Mineralocrticoid antagonist for 8 weeks
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BP response
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No BP response
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
• Deoxycorticosterone excess( Tumor, 17 alpha hydroxylase and 11 beta hydroxylase deficiency)
• Licorice ingestion
•Glucocorticoid resistance
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liddle's syndrome)

History and symptoms

de:Hyperaldosteronismus it:Iperaldosteronismo


Template:WikiDoc Sources